reviews for glp-1 weight loss treatments by doctors in denver. Retatrutide loss: Study shows 30% body weight Semaglutide GLP-1 Injections for Medical

For guidance on evaluating research peptide quality standards, see our how to choose a research peptide supplier guide and our comparison of best peptide companies in 2026

In STEP-8 (N=338), semaglutide 2.4 mg was compared head-to-head with liraglutide 3.0 mg at 68 weeks

Enhanced -cell function, adipose lipolysis, and insulin sensitization

Long-term considerations Maintenance dosing After reaching goal weight: Some continue at therapeutic dose indefinitely Others may reduce to lower maintenance dose (4-8 mg) Weight regain is common if medication is stopped Long-term studies are ongoing Duration of treatment Based on clinical trial data: Weight loss continues for at least 48-68 weeks Plateau may not occur even at 48 weeks Long-term (multi-year) data not yet available Treatment may be indefinite for weight maintenance Monitoring recommendations Regular check-ins should include: Weight and body composition Blood pressure and heart rate Blood glucose and HbA1c Lipid panel Liver and kidney function Review of symptoms and side effects Frequently asked questions What is the starting dose for retatrutide

Mix things up so you dont get bored swap quinoa for brown rice, or switch your greens from spinach to kale

As appetite is often reduced on GLP-1s, getting enough protein can be challenging